RxDoctor Payments DataLook up a doctor →

Joseph Woolley, MD

Internal Medicine · Saint George, UTNPI 1780800813

Payments from drug & device makers

$3,553,980in general payments, 2019–2025

Across 1,684 payments — averaging $2110.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$793K
  • Pfizer$761K
  • Novo Nordisk AS$615K
  • Amgen$459K
  • Boehringer Ingelheim$311K
  • Hoffmann-la Roche Limited$277K
  • plus $338K from 54 others
$14,291in research payments, 2019–2025

Across 3 payments — averaging $4763.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$14K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly15$792,668
Pfizer105$760,822
Novo Nordisk AS841$615,426
Amgen(2 entities)32$459,227
Boehringer Ingelheim46$311,238
Hoffmann-la Roche Limited8$276,727
Welch Allyn12$217,152
GSK28$57,628
Lexicon Pharmaceuticals, Inc.5$21,793
Boehringer Ingelheim International GmbH86$20,995
Genentech, Inc.3$11,900
AbbVie(2 entities)86$1,347
AstraZeneca(2 entities)46$1,042
Novartis56$1,005
Novo Nordisk44$604
Lilly USA, LLC42$522
Boston Scientific11$301
Johnson & Johnson30$291
Takeda Pharmaceuticals U.S.A., Inc.16$219
Nestle Healthcare Nutrition Inc.13$217
Sanofi-aventis U.S. LLC14$204
Merck13$204
Abbott14$200
Philips North America LLC10$189
Teva Pharmaceuticals USA, Inc.8$181
Lundbeck LLC7$167
Bayer9$149
Aimmune Therapeutics, Inc.8$125
Astellas Pharma US Inc1$100
Radius Health, Inc.6$100
Biohaven Pharmaceutical Holding Company Ltd.5$92
Amarin Pharma, Inc.5$86
Mylan Specialty L.p.4$85
Dexcom, Inc.5$83
Daiichi Sankyo Inc.4$79
Neurocrine Biosciences, Inc.3$65
Baxter Healthcare2$53
Biohaven Pharmaceuticals, Inc.3$49
Ironwood Pharmaceuticals, Inc3$43
Almatica Pharma LLC2$39
Otsuka America Pharmaceutical, Inc.2$36
IBSA Pharma Inc.2$34
Medtronic2$34
Phathom Pharmaceuticals, Inc.2$34
Alkermes, Inc.2$32
Idorsia Pharmaceuticals US Inc2$31
Exact Sciences2$30
ANI Pharmaceuticals, Inc.1$26
Tactile Systems Technology Inc2$26
Viatris Specialty LLC1$25
Sumitomo Pharma America, Inc.2$24
Nevro Corp.1$23
Vanda Pharmaceuticals Inc.1$22
Lucid Diagnostics Inc.1$21
Xeris Pharmaceuticals, Inc.1$21
Inspire Medical Systems, Inc.1$20
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$20
Supernus Pharmaceuticals, Inc.1$19
Strongbridge US Inc.1$18
Urovant Sciences Inc1$18

How this compares

$3,553,980 in reported general payments places this provider in the 95th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$589,877
Medicare patients
1,197
Services billed
9,884

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Saint George

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →